Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double Blind Study of Irbesartan vs. Amlodipine in Obese Hypertensive Subjects- The OBI Study

NCT00987662 is registered in ClinicalTrials.gov with Aristotle University Of Thessaloniki as lead sponsor.

NCT NCT00987662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00987662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double Blind Study of Irbesartan vs. Amlodipine in Obese Hypertensive Subjects- The OBI Study
Lead sponsor
Aristotle University Of Thessaloniki
Phase
Phase 4
Overall status
Withdrawn
Start date
January 31, 2012
Completion date
January 31, 2014
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, obesity